倧éªå€§åŠ(éªå€§)ã¯8æ28æ¥ã転å調ç¯å åãSbno2ãã骚ãåžåãããç ŽéªšçŽ°èãã®æ£åžžãªçްèèåã«å¿ é ã§ããããšãåäœã¬ãã«ã§æããã«ããããšã«æåãããšçºè¡šããã
ææã¯ãéªå€§ å ç«åŠããã³ãã£ã¢ç ç©¶ã»ã³ã¿ãŒ èªç¶å ç«åŠã®å¯©è¯éç·ææãæ¥æ¬åŠè¡æ¯èäŒç¹å¥ç ç©¶å¡ã®äžžå±±å¥å€ªå»åž«ãã®ç ç©¶ããŒã ã«ãããã®ãç ç©¶ã®è©³çްãªå 容ã¯ã7æ26æ¥ä»ãã§ãThe Journal of Experimental Medicineãã«æ²èŒæžã¿ã ã
ã现èèåããšã¯2å以äžã®åçš®ãããã¯ç°çš®ã®çްèå士ã现èèãèåãããããšã§åäžçްèãšãªãçŸè±¡ãæå³ããã人工çãªçްèèåæè¡ãªãããŠæäœå»çãå ç«åŠã®çºå±ãæããªãã£ãããšãèãããšã现èèåãçŸä»£å»åŠã«äžããã€ã³ãã¯ãã¯èšãç¥ããªããšãããæŽå²çèæ¯ããã现èèåã¯äžè¬ã«ã¯ç åäœãè¬å€ã«ãã£ãŠèªå°ãããã€ã¡ãŒãžã匷ããããã®çŸè±¡ãçºçéçšã现èååãšãã£ãçççå±é¢ã«ãããŠãéèŠãªåœ¹å²ãæãããŠããããšã¯æå€ã«ç¥ãããŠããªãã
äŸãã°ã粟åãšåµåã¯å粟éçšã§èåããéªšæ Œç现èã¯æçµååæ®µéã«ãããŠèåããã»ã¹ãçµãŠå€æ žã®å·šçްèãšãªããããã«ãç ŽéªšçŽ°èã¯å€æ žçްèã®ä»£è¡šæ Œã ãããã®çްèã¯éªšèœçްèäžã«ååšãããç ŽéªšçŽ°èååå å(RANKL:Receptor Activator of Nuclear Factor-kappa B Ligand)ããåæ žã®ãç ŽéªšçŽ°èåé§çްèãã«åããããŠããããã®èåãä¿é²ãããçµæãšããŠåœ¢äœãããã®ã ã
ãããŠè¶ é«éœ¢ç€ŸäŒãè¿ããæ¥æ¬ã«ãããŠããã®è§£æ±ºãç·å«ã®èª²é¡ãšãªã£ãŠããã®ããæ£è æ°ã1000äžäººãšããããã骚ç²ãããçãã§ããã骚ã¯äººäœã§æã硬ãéšäœã®ããã«å€åããªããããªã€ã¡ãŒãžãããããåçãšç Žå£ãç¹°ãè¿ããŠããã骚ç²ãããçã¯ç Žéªšçްèã«ããéªšç Žå£ã骚圢æãäžåãããšã«ãã£ãŠçããŠããŸãããã®äºé²ã®åãæãšããŠããæRANKLæäœããå®çšåããã€ã€ããããäžžå±±å»åž«ãã¯RANKLããã³ãã®äžæµã§æŽ»æ§åããã転åå å(éºäŒåã«çµåããŠãéºäŒåã®çºçŸã調ç¯ããã¿ã³ãã¯è³ª)çŸ€ã®æããèªç¶å ç«èª¿ç¯äœçšãå ±åããããšã§ãããããæ²»çã®æã€å±éºæ§ã«ã€ããŠãããŠããèŠéã鳎ãããŠããã
å®éãæRANKLæäœäœ¿çšã«äŒŽãå ç«ç°åžžãäœã«ã«ã·ãŠã (Ca)è¡çã«ããæ»äº¡äŸãªã©ã®å ±åæ°ã¯å¢å ããŠãããããRANKL以å€ã®ç Žéªšçްèãã¿ãŒã²ãããšãã骚ç²ãããçæ²»çæšçãæããã«ããããšã¯äŸç¶ãšããŠéèŠã ãRANKLããç ŽéªšçŽ°èåé§çްèãã®RANKLå容äœã§ãããRANKããšçµåãããšããNF-kBãããc-FosãããJdp2ãããNFATc1ãããMITFããªã©ã®è»¢åå åãæŽ»æ§åãããTRAPãããCTSKãããDC-STAMPããšãã£ãç ŽéªšçŽ°èç¹ç°çéºäŒå矀ã®çºçŸãèªå°ãããã
ç ŽéªšçŽ°èç¹ç°çéºäŒå矀ã®äžã§ããDC-STAMPã¯ç Žéªšçްèèåã®ãã¹ã¿ãŒã¬ã®ã¥ã¬ãŒã¿ãŒã§ããããšãç¥ãããŠãããDC-STAMPæ¬ æããŠã¹ããã¯åæ žã®ç Žéªšçްèãã圢æãããªãããããŠæè¿ã«ãªããç ŽéªšçŽ°èã«ãããDC-STAMPã®çºçŸã¯è»¢åå åMITFã«ãã£ãŠèªå°ãããç ŽéªšçŽ°èåé§çްèã§ã¯è»¢åæå¶å åãTal1ããDC-STAMPããã¢ãŒã¿ã«çµåããŠMITFã«ããDC-STAMPã®è»¢å掻æ§åããããã¯ããŠããããšãæããã«ããããããããããšãããç ŽéªšçŽ°èèåã¯è€æ°ã®è»¢åå åã«ãã£ãŠå³å¯ã«èª¿ç¯ãããŠãããšèããããŠãããšããã
ãŸãRANKL以å€ã«ããããŸããŸãªããµã€ãã«ã€ã³ã(现èéã§æ å ±ãäŒéããå å)ãç å埮çç©ã®åºæ¿ã転åå åNF-kBãæŽ»æ§åãããNF-kBã¯ç Žéªšçްèååã«å¿ é ã§ããã ãã§ãªããç åäœæ§ææåã«ããåç©çްè衚é¢ã®å容äœã¿ã³ãã¯è³ªãTLR(Toll-like receptor:ãã«æ§å容äœ)ãã®åºæ¿ã«ãã£ãŠãåŒ·ãæŽ»æ§åãããççæ§ãµã€ãã«ã€ã³ãèªå°ãããã
è¿å¹Žã«ãªããççæ§ãµã€ãã«ã€ã³ã®1çš®ã§ãããã€ã³ã¿ãŒãã€ãã³(IL)-10ããã転åå åãSTAT3ãäŸåçã«é µçŽ ãDExD/Hããªã«ãŒãŒãã¡ããªãŒãã«å±ãã転å調ç¯å åãSbno2(Strawberry notch homologue2)ããèªå°ããNF-kBã®æŽ»æ§åãæå¶ããããšã瀺ãããã
ããããããšãããSbno2ã¯ççæ§ãµã€ãã«ã€ã³ç£çãè² ã«å¶åŸ¡ããå åãšèããããããåäœã¬ãã«ã§ã®ãã®èªç¶å ç«å¿çã«æãã圹å²ãçççæ©èœã«ã€ããŠã¯æããã§ã¯ãªãã£ããããã§ç ç©¶ããŒã ã¯ä»åããã®çåã«çãããããããã¯ã¢ãŠãããŠã¹æè¡ãçšããSbno2ã®æ©èœè§£æã詊ã¿ãã®ã§ããã
Sbno2ã¯éªšé«ã§ã®çºçŸãé«ããè¡ç系现èã®äžã§ã¯ãã¯ããã¡ãŒãžãç ŽéªšçŽ°èã§ç¹ã«åŒ·ãçºçŸããŠããããšã確èªããããããã§ããããã®çްèã«ãããSbno2ã®æ©èœãæããã«ããç®çã§ããã¯ã¢ãŠãããŠã¹ãäœæããããšããã10é±éœ¢ã«ãããŠéçåãšæ¯ã¹è¥å¹²ã®äœéæžå°ãèªããããæé·é害ãçãããã®ã§ããã
ãã®äžæ¹ã§ãæãããªãã¯ããã¡ãŒãžã»å¥œäžçã»ãªã³ãçãªã©ã®ååç°åžžã¯èªããããŠãããããã¯ããã¡ãŒãžã®ççæ§ãµã€ãã«ã€ã³ç£çèœãNF-kBã®æŽ»æ§åãæ£åžžã§ãã£ããããããããšãããSbno2ã¯ä»¥åå ±åãããŠãããããªNF-kBã®æå¶äœçšã¯æããŠããªãããšãæãããšãªã£ãã®ã§ããã
次ã«Sbno2ããã¯ã¢ãŠãããŠã¹ã®éªšã®ãè§£æãè¡ããããããš10é±éœ¢ã«ãããŠèæãªéªšéã®äžæã確èªãããã倧çç³éªšç ããçºçããŠããããšã倿ãããçµç¹è§£æã§ã¯ç Žéªšçްèã®æ°ã¯æ£åžžã§ãã£ããã1现èåœããã®æ žã®æ°ãæžå°ããŠãããèåé害ãçãããã®ã§ãã(ç»å1)ãããã«ã骚圢æé床ã®äœäžãèªããããããšããã骚ã®åœ¢æãè¡ãã骚èœçްèãã®ååé害ã®ååšã瀺åãããã
å®éãin vitroã§Sbno2ããã¯ã¢ãŠãããŠã¹ç±æ¥ã®éªšèœçްèãå¹é€ãããšè»œåºŠã®ååé害ã芳å¯ããããããã¯ã¢ãŠãç±æ¥ã®éªšèœçްèã§ã¯éªšèœçްèååãä¿é²ããå åã§ãã Jagged1ã®çºçŸãèæã«æžåŒ±ããŠããããããå¹é€æ¶²äžã«å ãããšååéå®³ãææžãããããšãããSbno2㯠Jagged1ã®çºçŸãæ£ã«å¶åŸ¡ããããšã§é©åãªéªšèœçްèååãå®çŸãããŠããããšãæãããšãªã£ããæ¬¡ã«ãããã¯ã¢ãŠãç±æ¥ã®çްèã䜿ã£ãŠ in vitroã«ãããRANKLèªå°æ§ã®ç Žéªšçްèååãæ€èšãããšãããin vivoã§èгå¯ãããããã«ç Žéªšçްèãããã®æ žæ°ãèæã«äœäžããŠãã(ç»å1ã»2)ãåã ã®ç Žéªšçްèã®éªšåžå掻æ§ãšååããŒã«ãŒã®çºçŸç¶æ ã¯æ£åžžã§ãã£ãããšããããã®ç°åžžã¯èåé害ã«èµ·å ããŠãããšèããããã
ããã«ãIL-4èªå°æ§ã®ãã¯ããã¡ãŒãžèåçŸè±¡ããç°ç©ãç®äžã«ç眮ããéã«èгå¯ããããã¯ããã¡ãŒãžèåçŸè±¡ãéšåçã«é害ãããŠããããšãããSbno2ã¯ç Žéªšçްèã ãã§ãªããåºããã¯ããã¡ãŒãžã®èåãå¶åŸ¡ããŠããååã§ããããšãæãããšãªã£ãã®ã§ããã
ç¶ããŠãSbno2ãã©ã®ãããªã¡ã«ããºã ã§çްèèåãå¶åŸ¡ããŠããã®ããæããã«ããç®çã§ã现èèåãæ£ã«å¶åŸ¡ããããšãå ±åãããŠããéºäŒå矀ã®çºçŸç¶æ ãæ€èšããããšãããç ŽéªšçŽ°èèåã®ãã¹ã¿ãŒã¬ã®ã¥ã¬ãŒã¿ãŒã§ããDC-STAMPã®çºçŸãèæã«æžåŒ±ããŠããããšã倿ãããã§ãç ç©¶ããŒã ãã¬ãããŠã€ã«ã¹ãçšããŠããã¯ã¢ãŠãç±æ¥ã®ç Žéªšçްèã«DC-STAMPãçºçŸããããšãããèåé害ãå®å šã«ææžãããããšãããã£ãã®ã§ããã
次ã«ãDC-STAMPã®çºçŸãå¶åŸ¡ãã転åå å矀(ãTal1ãããPU.1ããMITFãc-FosãNFATc1ãNF-kB)ã®DC-STAMPããã¢ãŒã¿é å(éºäŒåã®è»¢åãå§ããé å)ãžã®çµåç¶æ ãããã¯ãããã³å ç«æ²éæ³ãã«ãŠæ€èšãããããããšãDC-STAMPçºçŸãæ£ã«å¶åŸ¡ããMITFã®çµåãæžåŒ±ããŠããäžæ¹ã§ãDC-STAMPã®çºçŸãæå¶ããTal1ã®çµåãããã¯ã¢ãŠãã®çްèã§å¢åŒ·ããããšãããã£ãã®ã§ãããããã§ãããã¯ã¢ãŠãç±æ¥ã®ç Žéªšçްèã§Tal1ã®ããã¯ããŠã³ãè¡ããããšãããç ŽéªšçŽ°èã®èåé害ã¯éšåçã«ææžãããããšãããã£ãã
ããã«ãSbno2ã¯Tal1ãšçŽæ¥çµåããããšã«ãããTal1ã®æŽ»æ§ãæå¶ããŠããããšãå ç«æ²éæ³ãšãã¬ããŒã¿ãŒã¢ãã»ã€ã(調ã¹ããéºäŒåãèå éºäŒåã«çœ®ãæããããšã§ãèå æž¬å®ã§éºäŒåã®çºçŸ(掻æ§)ç¶æ ãç®ã«èŠãã圢ã«ããããš)ã«ãã確èªãããããšãããSbno2ã«ããTal1æå¶ãä»ããDC-STAMPçºçŸäº¢é²ã«ããç ŽéªšçŽ°èèåä¿é²æ©æ§ãåããŠæãããšãªã£ãã®ã§ãã(ç»å3)ã
çŸåšãç ŽéªšçŽ°èååãæå¶ãã骚ç²ãããçæ²»çè¬ã®éçºãæ¥ãããã§é²ããããŠããããããããå»è¬åã®å€ãã¯å ç«ç³»ã®ããä¹±äœçšãäœCaè¡çãé¡éªšå£æ»ãªã©ã®å¯äœçšãæã€ãããååæå¶ãäœçšæ©åºãšããªãæ°ããªæ²»çè¬ã®éçºãåæãããŠããç¶æ ã ã£ããSbno2ãæ¬ æããç ŽéªšçŽ°èã¯ååãæ£åžžã§ããäžæ¹ã§èåã ããé害ãããå ç«ç³»ã«ã¯ç°åžžãèŠãããªãã£ãããšããããã®ååãããå®å šãªæ¬¡äžä»£ã®éªšç²ãããçæ²»çè¬ã®æšçãšãªãããšãæåŸ ããããšããŠããã
